World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 30 March 2015
Main ID:  NCT02187614
Date of registration: 07/07/2014
Prospective Registration: Yes
Primary sponsor: Hamad Medical Corporation
Public title: Efficacy Study of Different Analgesic Options in Kidney Stone Pain Management
Scientific title: A Double Blind, Multi-arm Randomized Control Trial, for Efficacy of Intramuscular Diclofenac Versus Intravenous Morphine Versus Intravenous Paracetamol, in Renal Colic Emergency Department Pain Management
Date of first enrolment: August 2014
Target sample size: 1645
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT02187614
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment  
Phase:  Phase 4
Countries of recruitment
Qatar
Contacts
Name:     Prof. Peter A Cameron, MD,FACEM
Address: 
Telephone:
Email:
Affiliation:  Hamad Medical Corporation
Name:     Dr.Sameer A. Pathan, MBBS, MCEM
Address: 
Telephone:
Email:
Affiliation:  Hamad Medical Corporation
Key inclusion & exclusion criteria

Inclusion Criteria:

- Age >=18 years and < 65 years

- Acute onset, one side flank or loin pain, with or without radiation to groin or
genital areas.

- Pain intensity on NRS more than or equal to 4. (Moderate to Severe Pain)

- Diagnosis confirmed by non contrast CT KUB within the ED visit.

Exclusion Criteria:

- Traumatic flank pain

- Pregnancy

- Known renal failure or impairment

- Known allergy to morphine, diclofenac or paracetamol

- Bronchial asthma

- Previously enrolled in the study.

- Use of any analgesia in last 6 hour.



Age minimum: 18 Years
Age maximum: 65 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Urinary Calculi
Renal Colic
Intervention(s)
Drug: Paracetamol
Drug: Morphine
Drug: Placebos
Drug: Diclofenac
Primary Outcome(s)
The proportion of patients achieving a reduction of >50% on Numerical Rating Scale (NRS-11) from the initial NRS recorded at the end of 30 minutes in each study arm. [Time Frame: at 30 minutes after analgesia]
Secondary Outcome(s)
reduction in mean NRS [Time Frame: at 30, 60 and 90 minutes after analgesia]
Secondary ID(s)
Hamad Medical Corporation-MRC
IRB Number: 14-00059
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history